Arecor Therapeutics PLC

AREC

Company Profile

  • Business description

    Arecor Therapeutics PLC is a focused biopharmaceutical company. The company is transforming patient care by bringing medicines to market through the enhancement of existing therapeutic products. By applying an proprietary formulation technology platform, Aresta. It is developing a portfolio of proprietary products in diabetes and other indications and working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of their therapies. Geographically, it operates in the UK, Europe (excl. UK) & Middle East, and the USA, out of which the majority is from the Europe (excl. UK) & Middle East.

  • Contact

    Chesterford Research Park
    Little Chesterford
    Saffron WaldenCB10 1XL
    GBR

    T: +44 1223426060

    E: [email protected]

    https://www.arecor.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    33

Stocks News & Analysis

stocks

ASX tech share tracking below guidance

Moat Rating downgraded for overvalued shares.
stocks

After plunge ASX blue chip undervalued

This company earns a moat from our analysts.
stocks

Older cohorts the budget losers, not necessarily the ASX listed insurers

Proposed legislation removes health insurance rebates.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,717.0082.40-0.94%
CAC 408,117.42135.661.70%
DAX 4024,732.28331.631.36%
Dow JONES (US)49,884.31520.431.05%
FTSE 10010,432.34101.790.99%
HKSE25,651.12146.73-0.57%
NASDAQ26,229.44358.731.39%
Nikkei 22559,804.41746.18-1.23%
NZX 50 Index12,761.03213.29-1.64%
S&P 5007,426.0672.450.99%
S&P/ASX 2008,496.6076.50-0.89%
SSE Composite Index4,162.187.35-0.18%

Market Movers